Replies to post #29367 on MannKind Corp. (MNKD)

[parkourstar]

You do realize that in the nine months that Sanofi actually put effort into selling afrezza, they far outperformed anything that Mannkind has done since -- both in Nrx and refills -- don't you?

And to the best of my knowledge, Mannkind has done nothing for the spirometry issue beyond offering to lend physicians -- who must call request one -- a spirometer that can be bought for $50 on Amazon. Do you really think has had an impact?

And titration? What have they changed? The dosing instructions are the same as when first launched. There is no additional information about proper titration that I can find.